Top Markets
#1 Pleasing Gold Pleasing Gold +468.74%
#2 Islamic Coin Islamic Coin +154.24%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +47.04%
#5 DogBull DogBull +35.86%
#6 ORDI ORDI +20.39%
#7 Nockchain Nockchain +18.86%
#8 PondCoin PondCoin +17.46%
#9 rsERG rsERG +17.37%
#10 Merlin's Seal BTC Merlin's Seal BTC +16.35%
Coin of the day
Pleasing Gold Pleasing Gold
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Lukas Biomedical Inc. Lukas Biomedical Inc.

Lukas Biomedical Inc.

6814
Kedudukan dalam Saham #27925
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc.... Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.
Harga Saham
$0.70911832
Modal Pasaran
$29.69M
Perubahan (1 hari)
0.45%
Perubahan (1 tahun)
-9.36%
Negara
TW
Perdagangan Lukas Biomedical Inc. (6814)

Kategori

Healthcare
Sejarah pecahan saham untuk Lukas Biomedical Inc. (6814)
Saham Lukas Biomedical Inc. (simbol: 6814) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 20, 2026.
Satu saham 6814 yang dibeli sebelum Aug 20, 2026 kini bersamaan dengan 0 saham 6814.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH